Indications and uses
Indications and usage : After using the serum, apply the emulsion to the entire face evenly along the skin texture like massaging the entire face.
Indications and usage : After using the serum, apply the emulsion to the entire face evenly along the skin texture like massaging the entire face.
Dosage and administration : Take a proper amount of product, and spread it evenly over the entire face.
Active ingredient : ALLANTOIN 0.5%
Inactive ingredient : WATER, HYDROGENATED POLYDECENE, BUTYLENE GLYCOL, GLYCERIN, TRIETHYLHEXANOIN, HUMAN BONE MARROW STEM CELL CONDITIONED MEDIA, CITRUS PARADISI (GRAPEFRUIT) FRUIT EXTRACT, BEHENYL ALCOHOL, GLYCERYL STEARATE, PEG-100 STEARATE, BEHENIC ACID, ISOSTEARIC ACID, STEARIC ACID, HYDROGENATED LECITHIN, POLYGONUM MULTIFLORUM ROOT EXTRACT, ACANTHOPANAX SENTICOSUS (ELEUTHERO) ROOT EXTRACT, PORTULACA OLERACEA EXTRACT, PANAX GINSENG ROOT EXTRACT, ASPARAGUS COCHINCHINENSIS ROOT EXTRACT, 1,2-HEXANEDIOL, CARBOMER, PHENOXYETHANOL, PEG-5 GLYCERYL STEARATE, GLYCERYL STEARATE SE, POTASSIUM HYDROXIDE, ALTHAEA ROSEA ROOT EXTRACT, ALOE BARBADENSIS LEAF EXTRACT, GANODERMA LUCIDUM (MUSHROOM) EXTRACT, GRIFOLA FRONDOSA EXTRACT, INONOTUS OBLIQUUS (MUSHROOM) EXTRACT, SPARASSIS CRISPA EXTRACT, PHELLINUS LINTEUS EXTRACT , CERAMIDE 3, ADENOSINE, LAVANDULA ANGUSTIFOLIA (LAVENDER) OIL, MELALEUCA ALTERNIFOLIA (TEA TREE) LEAF OIL, EUCALYPTUS GLOBULUS LEAF OIL, GERANIUM MACULATUM OIL, ROSMARINUS OFFICINALIS (ROSEMARY) LEAF OIL, MENTHA PIPERITA (PEPPERMINT) OIL
Purpose : Skin Protectant
Warning : Keep out of reach of children and babies. For external use only. Avoid contact with eyes. Discontinue use if signs of irritation and/or rash appear.
Keep out of reach of children and babies.
Indications and usage : After using the serum, apply the emulsion to the entire face evenly along the skin texture like massaging the entire face.
Dosage and administration : Take a proper amount of product, and spread it evenly over the entire face.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 60949-060-01 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4545-60a7-e053-dbdaa90a05bd | 554d5e2a-a73b-4291-9726-6adf6d265aa9 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60949-060-01 | By Pharmicell Lab Luxury Cell Performance Emulsion | 130 mL in 1 CARTON | CREAM | 130 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ALLANTOIN | ACTIVE INGREDIENT | 344S277G0Z | 1 | |
| ALLANTOIN | ACTIVE MOIETY | 344S277G0Z | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 60949-060 | 60949-060-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALLANTOIN | 344S277G0Z | ACTIB |
| WATER | 059QF0KO0R | IACT |
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a51869fd-48b9-405a-ba25-f1328ca35372 | 554d5e2a-a73b-4291-9726-6adf6d265aa9 | 2013-07-07 | Warnings | a51869fd-48b9-405a-ba25-f1328ca35372 554d5e2a-a73b-4291-9726-6adf6d265aa9 |
Adverse event summaries are temporarily unavailable. Other product information remains available.